These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26120970)

  • 1. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.
    Roy S; Benz F; Vargas Cardenas D; Vucur M; Gautheron J; Schneider A; Hellerbrand C; Pottier N; Alder J; Tacke F; Trautwein C; Roderburg C; Luedde T
    J Dig Dis; 2015 Sep; 16(9):513-24. PubMed ID: 26120970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
    Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
    Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis.
    Roderburg C; Luedde M; Vargas Cardenas D; Vucur M; Mollnow T; Zimmermann HW; Koch A; Hellerbrand C; Weiskirchen R; Frey N; Tacke F; Trautwein C; Luedde T
    J Hepatol; 2013 Apr; 58(4):736-42. PubMed ID: 23183523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    Knabel MK; Ramachandran K; Karhadkar S; Hwang HW; Creamer TJ; Chivukula RR; Sheikh F; Clark KR; Torbenson M; Montgomery RA; Cameron AM; Mendell JT; Warren DS
    PLoS One; 2015; 10(4):e0124411. PubMed ID: 25923107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
    He C; Shu B; Zhou Y; Zhang R; Yang X
    Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
    Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
    J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
    Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
    Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III.
    He X; Wang Y; Fan X; Lei N; Tian Y; Zhang D; Pan W
    J Hepatol; 2020 Mar; 72(3):519-527. PubMed ID: 31738999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
    Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
    J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
    Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
    Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
    Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
    Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.